The agenda for INVEST 2019 has been finalized as we gear up for our annual flagship conference in Chicago, April 23-24 and invite speakers and startups to apply.
Final agenda for INVEST 2019 published as MedCity invites speaker applications
Imfinzi looks flimsy in AstraZeneca’s Phase III head and neck cancer study
Results of the Phase III EAGLE study leave Merck’s Keytruda and Bristol’s Opdivo as the dominant players in the space of HNSCC after progression on platinum-based chemotherapy.
Texas startup brings in $1.7M for telehealth job marketplace
Enzyme Health, which was founded this year, secured the seed funding from Silverton Partners and private investors.
Healthcare spending slows, but still reaches $3.5 trillion
The 3.9 percent jump in spending levels represents a drop from the 4.8 percent increase seen in 2016 and the 5.5 percent hikes seen in 2015 and 2015.
San Francisco-based startup Solv’s path to 3 million same-day patient visits
The company’s technology allows patients to book same-day appointments à la OpenTable, pay for medical bills from their phone using and imitate video calls with doctors using their mobile browser.
MedCity News StartUPDATES
Funding updates, job changes, and other news from the MedCitizens community.
Mayo Clinic collaborates with medication adherence startup MyMeds
Through their partnership, MyMeds users will be able to access medication-related educational content from Mayo Clinic.
Moderna raises more than $600M in biggest-ever biotech IPO
The offering closes on Tuesday and follows a string of very large IPOs by biotech companies over the last couple of months. Moderna’s February $500 million Series G round valued the company at $7 billion.